Management of Dropping Hemoglobin After Discharge
For patients with dropping hemoglobin after discharge, urgent evaluation is required to identify the cause of blood loss, with immediate hospital readmission if hemoglobin drops ≥2 g/dL or if the patient shows signs of hemodynamic instability. 1
Initial Assessment
Determine severity of anemia based on:
Evaluate for active bleeding:
Immediate Management
For Severe/Major Bleeding (Hb drop ≥2 g/dL or hemodynamic instability)
- Immediate hospital readmission 1
- Stop any anticoagulant or antiplatelet medications 1
- Initiate appropriate measures to control bleeding:
- Volume resuscitation 1
- Consider blood transfusion if hemoglobin <7 g/dL or patient is symptomatic 1
- For patients on anticoagulants, administer appropriate reversal agents based on the specific anticoagulant 1:
- VKA (warfarin): Fresh frozen plasma, 4-factor PCC, vitamin K
- DOACs: 4-factor PCC, idarucizumab (for dabigatran), andexanet alfa (for apixaban/rivaroxaban)
- Heparin/LMWH: Protamine sulfate
- Platelet inhibitors: Platelet transfusion
For Non-Severe Bleeding (Hb drop <2 g/dL, hemodynamically stable)
- Consider outpatient management if stable 1
- Hold anticoagulant dose while bleeding is active 1
- Do not reverse anticoagulation if bleeding can be otherwise controlled 1
- Monitor hemoglobin levels closely 1
Diagnostic Workup
Complete blood count with reticulocyte count to determine if anemia is regenerative or non-regenerative 1
Iron studies (ferritin, TIBC, transferrin saturation) to evaluate for iron deficiency 1
Based on MCV classification 1:
- Microcytic (MCV <80 fL): Iron profile workup
- Normocytic (MCV 80-100 fL): Evaluate for renal function, inflammation
- Macrocytic (MCV >100 fL): Check B12, folate, thyroid function
Gastrointestinal evaluation:
Treatment Approach
Iron Deficiency Anemia
Oral iron supplementation:
Parenteral iron only when:
Blood Transfusion
- Transfuse if hemoglobin <7 g/dL in most patients 1
- Consider higher threshold for patients with:
- Use single-unit transfusion policy when possible 1
Erythropoiesis-Stimulating Agents
- Not recommended for routine use in anemia associated with acute illness 1
- May be considered in specific situations:
Follow-up
Monitor hemoglobin concentration and red cell indices at regular intervals:
Provide additional oral iron if hemoglobin or MCV falls below normal 1
Consider further investigation if:
Common Pitfalls to Avoid
- Failing to identify the cause of ongoing blood loss 1
- Normalizing blood pressure too aggressively during active hemorrhage 1
- Administering iron therapy without identifying the underlying cause of iron deficiency 1
- Continuing anticoagulants without consulting the primary service managing anticoagulation 1
- Overlooking hospital-acquired causes of anemia such as frequent blood draws, parenteral hydration, and central venous access 3